Published in J Hypertens on March 01, 2010
Postmenopausal hypertension. Am J Hypertens (2011) 1.22
Hypertension in postmenopausal women. Curr Hypertens Rep (2012) 1.07
Sympathetic regulation of vascular function in health and disease. Front Physiol (2012) 1.07
T lymphocytes and vascular inflammation contribute to stress-dependent hypertension. Biol Psychiatry (2012) 1.03
Depression and cardiovascular disease: an update on how course of illness may influence risk. Curr Psychiatry Rep (2014) 0.91
A sympathetic view of human obesity. Clin Auton Res (2012) 0.90
Advances in sympathetic nerve recording in humans. Front Physiol (2012) 0.86
Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies. Neuropsychiatr Dis Treat (2015) 0.81
The impact of mood and anxiety disorders on incident hypertension at one year. Int J Hypertens (2014) 0.80
The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion. Clinics (Sao Paulo) (2013) 0.80
Change in sympathetic nerve firing pattern associated with dietary weight loss in the metabolic syndrome. Front Physiol (2011) 0.80
Association of anxiety with resistance vessel dysfunction in human atherosclerosis. Psychosom Med (2013) 0.77
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic Syndrome. Front Neurosci (2016) 0.77
Blood pressure change during phacoemulsification and femtosecond laser-assisted cataract surgery. Int J Ophthalmol (2016) 0.75
Role of peripheral vascular resistance for the association between major depression and cardiovascular disease. J Cardiovasc Pharmacol (2015) 0.75
Occupational Disparities in the Association between Self-Reported Salt-Eating Habit and Hypertension in Older Adults in Xiamen, China. Int J Environ Res Public Health (2016) 0.75
Symptoms of anxiety and mood disturbance alter cardiac and peripheral autonomic control in patients with metabolic syndrome. Eur J Appl Physiol (2012) 0.75
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet (2009) 10.53
Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol (1985) (2010) 9.76
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Circulation (2013) 3.44
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension (2003) 3.29
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation (2011) 2.88
Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry (2008) 2.43
Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension (2006) 2.41
Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial. BMJ (2012) 2.23
Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens (2007) 2.09
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation (2012) 2.07
Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol (2009) 2.04
Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension (2010) 2.01
Endogenous estrogens influence endothelial function in young men. Circ Res (2003) 1.98
Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension. Hypertension (2007) 1.90
QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol (2008) 1.85
Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens (2011) 1.80
The sympathetic nervous system and the metabolic syndrome. J Hypertens (2007) 1.80
Sympathetic activation in chronic renal failure. J Am Soc Nephrol (2008) 1.80
Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J (2005) 1.80
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr (2008) 1.75
Autonomic control of the heart and renal vascular bed during autonomic dysreflexia in high spinal cord injury. Clin Auton Res (2002) 1.75
The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J (2012) 1.74
Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals. J Hypertens (2011) 1.70
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol (2012) 1.66
Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery. J Am Soc Nephrol (2009) 1.60
Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. Am J Clin Nutr (2013) 1.59
Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J (2010) 1.56
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension. Hypertension (2012) 1.54
Sympathetic and cardiac baroreflex function in panic disorder. J Hypertens (2002) 1.53
Increased brain serotonin turnover in panic disorder patients in the absence of a panic attack: reduction by a selective serotonin reuptake inhibitor. Stress (2007) 1.52
Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension (2006) 1.51
Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA (2012) 1.50
Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion. J Hypertens (2004) 1.46
Increased cardiac sympathetic drive in renovascular hypertension. J Hypertens (2002) 1.46
Angiotensin II and norepinephrine release: interaction and effects on the heart. J Hypertens (2005) 1.44
Interactions between leptin and the human sympathetic nervous system. Hypertension (2003) 1.44
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J Hypertens (2012) 1.37
New drugs, procedures, and devices for hypertension. Lancet (2012) 1.32
Beta-adrenoceptor genotype influences the response to carvedilol in patients with congestive heart failure. Pharmacogenetics (2003) 1.32
Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia. Proc Natl Acad Sci U S A (2005) 1.24
Recurrent postural vasovagal syncope: sympathetic nervous system phenotypes. Circ Arrhythm Electrophysiol (2011) 1.22
Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin Exp Pharmacol Physiol (2008) 1.21
Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation (2011) 1.18
Dysautonomias: clinical disorders of the autonomic nervous system. Ann Intern Med (2002) 1.15
Relation between QT interval variability and cardiac sympathetic activity in hypertension. Am J Physiol Heart Circ Physiol (2011) 1.15
Increased suicide rate in the middle-aged and its association with hours of sunlight. Am J Psychiatry (2003) 1.14
Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med (2006) 1.13
Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens (2007) 1.12
Cardiorespiratory response to exercise after renal sympathetic denervation in patients with resistant hypertension. J Am Coll Cardiol (2011) 1.12
Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med (2006) 1.10
Blood pressure and sympathetic nervous system response to renal denervation. Hypertension (2012) 1.08
Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover. J Physiol (2011) 1.03
Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes (2009) 1.02
Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol (2008) 1.02
Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity? J Appl Physiol (1985) (2006) 1.01
Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol (2013) 1.01
Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. J Hypertens (2012) 1.00
Low-frequency galvanic vestibular stimulation evokes two peaks of modulation in skin sympathetic nerve activity. Exp Brain Res (2012) 0.98
Jugular venous overflow of noradrenaline from the brain: a neurochemical indicator of cerebrovascular sympathetic nerve activity in humans. J Physiol (2009) 0.97
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol (2005) 0.97
Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington's disease. J Physiol (2012) 0.96
Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J Clin Endocrinol Metab (2004) 0.96
Methylation of the SLC6a2 gene promoter in major depression and panic disorder. PLoS One (2013) 0.96
The influence of aging on the human sympathetic nervous system and brain norepinephrine turnover. Am J Physiol Regul Integr Comp Physiol (2002) 0.95
Low-frequency sinusoidal galvanic stimulation of the left and right vestibular nerves reveals two peaks of modulation in muscle sympathetic nerve activity. Exp Brain Res (2011) 0.95
The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. J Clin Endocrinol Metab (2010) 0.95